has received a revised takeover offer from Brookfield Capital Partners.
The proposal is for acquisition of all shares in Healthscope by way of and off-market takeover offer of $2.42 cash per share and a simultaneous scheme of arrangement of $2.55 per share.
Healthscope has knocked back rival bidder BGH Capital's request for due diligence on the basis that the proposal is significantly less attractive than the Brookfield proposal.
Brookfield on the other hand has been granted exclusive due diligence to facilitate a binding offer for Healthscope.
Last month BGH Capital and its partners put forward a $4.1 billion bid for the private healthcare provider.
Shares in Healthscope (ASX:HSO)
are trading 10.82 per cent higher to $2.31.